Nishida et al. found that cancer-derived EVs were disrupted by macrophages in response to antibody therapy with anti-CD9 or anti-CD63 in a metastatic BCa cancer mouse model and drastically suppressed metastatic cells [90]. The gene discussed is CD9; the disease is cancer.